Gilead expects to make 2m courses of its coronavirus drug Remdesivir by year end

30/07/2020 | 20:08 GMT

Part of the firm's earnings announcement.

Hopes are high for the drug as a treatment for COVID-19. News opver the past months on the drug have given 'risk' assets a boost when its hit the headlines.

ADVERTISEMENT - CONTINUE READING BELOW

Best in 2026

Sponsored

General Risk Warning

Best Futures Brokers in USA for 2026: Detailed Comparison

Best Prediction Market Platforms in 2026: Detailed Comparison

Best Online Brokers in 2026: Detailed Comparison

Best Prop Firm in 2026: Detailed Comparison

Best Forex Brokers in 2026: Detailed Comparison

ADVERTISEMENT - CONTINUE READING BELOW

Telegram Community

Gain Access

!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}